Henriette Ytting Lambert
Clinical Associate Professor
Department of Clinical Medicine
Kettegård Allé 30, 2650 Hvidovre
Member of:
Internal Medicine: Gastroenterology and Hepatology
1 - 1 out of 1Page size: 25
- 2020
- Published
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
Lynch, K. D., Chapman, R. W., Keshav, S., Montano-Loza, A. J., Mason, A. L., Kremer, A. E., Vetter, M., de Krijger, M., Ponsioen, C. Y., Trivedi, P., Hirschfield, G., Schramm, C., Liu, C. H., Bowlus, C. L., Estes, D. J., Pratt, D., Hedin, C., Bergquist, A., de Vries, A. C., van der Woude, C. J. & 16 others, , 2020, In: Clinical Gastroenterology and Hepatology. 18, 1, p. 179-187.e6Research output: Contribution to journal › Journal article › Research › peer-review
ID: 33970192
Most downloads
-
68
downloads
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
Research output: Contribution to journal › Journal article › Research › peer-review
Published